NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $258,000 | -17.3% | 3,133 | -4.9% | 0.28% | +11.2% |
| Q4 2019 | $312,000 | +7.6% | 3,296 | -1.2% | 0.25% | +4.6% |
| Q3 2019 | $290,000 | -4.6% | 3,335 | +0.3% | 0.24% | -3.6% |
| Q2 2019 | $304,000 | -11.6% | 3,325 | -7.1% | 0.25% | -16.8% |
| Q1 2019 | $344,000 | +13.5% | 3,579 | +1.4% | 0.30% | -0.3% |
| Q4 2018 | $303,000 | +8.2% | 3,529 | +8.5% | 0.30% | +31.7% |
| Q3 2018 | $280,000 | +13.8% | 3,252 | 0.0% | 0.23% | +49.3% |
| Q2 2018 | $246,000 | -48.4% | 3,252 | -44.9% | 0.15% | -42.2% |
| Q1 2018 | $477,000 | +7.4% | 5,898 | +11.5% | 0.26% | +1.9% |
| Q4 2017 | $444,000 | -2.2% | 5,290 | 0.0% | 0.26% | +0.4% |
| Q3 2017 | $454,000 | +2.7% | 5,290 | 0.0% | 0.26% | +8.0% |
| Q2 2017 | $442,000 | +12.5% | 5,290 | 0.0% | 0.24% | +8.7% |
| Q1 2017 | $393,000 | +2.1% | 5,290 | 0.0% | 0.22% | -6.8% |
| Q4 2016 | $385,000 | +13.2% | 5,290 | +23.0% | 0.24% | +2.2% |
| Q3 2016 | $340,000 | – | 4,300 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |